Clinical Trial Update: MicroRNAs in Patients With Neurofibromatosis Type 1

View source ↗

Summary

Completed clinical trial evaluating microRNAs in patients with Neurofibromatosis Type 1, including glioma cases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• Neurofibromatosis Type

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Glioma, Neurofibromatosis Type 1 | Status: COMPLETED